WSR 24-21-081

RESCISSION OF EMERGENCY RULES

DEPARTMENT OF HEALTH

[Filed October 15, 2024, 4:43 p.m., effective November 11, 2024]

This memo serves as notice that effective November 11, 2024, the pharmacy quality assurance commission (commission) is rescinding the CR-103E for Naloxone nasal spray as over-the-counter status, WAC 246-945-030 and 246-945-034, which was filed on August 1, 2024, and published in WSR 24-16-085.

The commission is rescinding this CR-103E because permanent rule making has been completed to update these two WAC sections. The permanent rule was filed as WSR 24-21-069 on October 11, 2024, and becomes effective November 11, 2024.

Individuals requiring information on this rule should contact Haleigh Mauldin, pharmacy quality assurance commission program consultant, at PharmacyRules@doh.wa.gov.

Tami M. Thompson

Regulatory Affairs Manager